Trevena to Host Conference Call on March 8th to Discuss Full Year 2016 Financial Results Mar 2, 2017 7:00 am EST
Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain Feb 21, 2017 7:00 am EST
Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain Jan 4, 2017 7:00 am EST
Trevena Reports Third Quarter 2016 Financial Results and Provides Corporate Update Nov 3, 2016 7:00 am EDT
Trevena to Webcast Thought Leader Symposium on Acute Pain Management and Present at the 2016 Annual Meeting of the American Society of Anesthesiologists Oct 17, 2016 4:16 pm EDT